Drugs and Medication for Kidney Disease

Researchers are encouraged to submit abstracts showcasing advancements in drug therapies for various kidney conditions, including chronic kidney disease, glomerulonephritis, diabetic nephropathy, and electrolyte disorders. Abstracts presenting clinical trials, pharmacokinetic studies, drug safety assessments, and pharmacogenomic research related to kidney disease medications are highly welcomed.

Attendees can anticipate a comprehensive program featuring presentations on the latest developments in nephrology pharmacotherapy, evidence-based prescribing practices, medication adherence strategies, and drug interactions management. This track offers a platform for collaboration, knowledge dissemination, and interactive discussions among nephrologists, pharmacists, clinical researchers, and pharmaceutical industry professionals interested in optimizing drug therapy for kidney disease.

 

    Related Conference of Drugs and Medication for Kidney Disease

    June 13-14, 2024

    9th World Kidney Congress

    Barcelona, Spain
    July 25-26, 2024

    28th European Nephrology Conference

    Frankfurt, Germany
    October 03-04, 2024

    22nd International Conference on Nephrology, Urology and Therapeutics

    Singapore City, Singapore

    Drugs and Medication for Kidney Disease Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in